Login / Signup

Influenza surveillance capacity improvements in Africa during 2011-2017.

Ledor S IgbohMeredith McMorrowStefano TempiaGideon O EmukuleNdahwouh Talla NzussouoMargaret McCarronThelma WilliamsVashonia WeatherspoonAnn MoenDerrar FawziRichard NjouomEmmanuel NakouneCoulibaly DauodaHugo Kavunga-MemboMary OkeyoJean Michel HeraudIvan Kiggundu MambuleSamba Ousmane SowAlmiro TivaneAdamou LagareAdedeji AdebayoNdongo DiaVida MmbagaIssaka MamanJulius LutwamaPaul SimusikaSibongile WalazaPunam MangtaniPatrick Nguipdop-DjomoCheryl CohenEduardo Azziz-Baumgartnernull null
Published in: Influenza and other respiratory viruses (2020)
Despite declines in external surveillance funding, ANISE countries gained additional laboratory testing capacity and continued influenza testing and reporting to WHO. These gains represent important achievements toward sustainable surveillance and epidemic/pandemic preparedness.
Keyphrases
  • public health
  • sars cov
  • coronavirus disease
  • adverse drug
  • infectious diseases
  • drug induced